Senior insider sale
President & CEO at NEKTAR THERAPEUTICS — senior position signals high conviction
$160.7K
2.63K shares
What this filing means
ROBIN HOWARD W plans to sell 2.63K shares of NEKTAR THERAPEUTICS valued at approximately $160.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/18/2026ACC: 0001959173-26-001149
DirectorOfficer· President & CEO
Since Aug 2018
2.63K
Shares to sell
$160.7K
Approx. market value
423.00
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/13/2026
423.00Total acquired423.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/13/2026 | Restricted Stock Vesting Compensation | 423.00 | — |
| Total | 423.00 | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.21K
Market value
$129.8K
11/25/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
423.00
Market value
$30.9K
2/18/2026
Total
Units
2.63K
Value
$160.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/25/2025 | 2.21K | $129.8K | — | Completed |
| Planned — Approximate Date | ||||
2/18/2026 | 423.00 | $30.9K | NASDAQ | Planned |
| Total | 2.63K | $160.7K | ||